News and Comments

Biotech Firms with Guaranteed Growth Potential

  Thursday, July 07, 2016

Good news is not always great news that makes a difference. In the drug industry, clinical trial results that demonstrate a drug has fulfilled the requirements of the trials, including the primary and secondary endpoints does not always guarantee that the drug will be successful if and when it hits the market. Experience and follow up on certain firms enables us to see the real light at the end of the tunnel, not just celebrate reaching the end of it without knowing what to expect outside. This makes a big difference.  More...

THERAVANCE: BECAME TEMPTING TO INVESTORS ANR TO ITS PARTNER

  Monday, January 07, 2013

Using scientific skills towards building pipelines of promising products does not guarantee a happy ending for a small biotech firm. Pipelines’ breakthroughs need managements’ capabilities and swiftness of actions, which would walk them through the safest and fastest road towards approvals.  We believe Theravance (THRX) has benefited from both its scientists and management. The firm has come nearer than ever to reaching a happy beginning of substantial growth, or perhaps, a happy ending through acquisition, probably, by its partner GlaxoSmithKline (GSK).  More...


Recent Postings


Archive


Tags

Onyx (ONXX) Agenus (AGEN Global Cell Therapeutics (GBT) PTC Therapeutics (PTCT) Agenus (AGEN) Intercept (ICPT) SERES THERAPEUTICS (MCRB) ZALTRAP™ Cytokinetics (CYTK) ARGOS (ARGS) Bristol-Myers Squibb (BMY) AERIE PHARMACEUTICALS C4 Therapeutics Idenix (IDIX) GUARDIAN HEALTH CompuGen (CGEN) Alnylam (ALNY) Sanofi (SNA) Ionis (IONS) RenenxBio (RGNX) Abbott Laboratories (ABT) Gilead (GILD) Sangamo (SGMO) Jazz Pharmaceuticals (JAZZ) Array Pharmaceuticals (ARRY) Vitae Pharmaceuticals (VTAE) Herceptin HALOZYME (HALO) Galena (GALE) Roche (RHHBY) ARCA (ABIO) Intermune (ITMN) Spike Therapeutics (ONCE) Genentech Endometrial Cancer Pluristem (PSTI) Human Longevity (HLI) Illumina (ILMN) Sanofi (SNY) ABBVIE (ABBV) Prosensa (RNA) Sanofi-Aventis (SAN) Dendreon (DNDN) SYNTA (SNTA) VANDA (VNDA) Multiple Myeloma Human Genome Sciences (HGSI) Inovio (INO) Revlimid (lenolidamide) Editas (EDIT) AGOS (ARGS) Micromet (MITI) Incyte (INCY) KITE (KITE) Trastuzumab-DM1 Roche (ROCHE) Ariad (ARIA) Auspex (ASPX) GlaxoSmithKline (GSK) IDERA (IDRA) INNOVIVA (INVA) Rapamune Valeant Pharmaceuticals International (VRX) Prolor Biotech (PBTH) Amgen (AMGN) REGULUS (RGLS) Merck (MRK) Dynavax (DVAX) Theravance Bio Pharma (TBPH) Xoma (XOMA) Intrexon (XON) Sarepta (SRPT) AstraZeneca (AZN) Velcade (bortezomib) MODERNA galapagos (GLPG) Theravance (THRX) Mirati Therapeutics (MRTX) Seattle Genetics (SGEN) ADVENTRIX (ANX) NANTKWEST (NK) Benlysta (belimumab) Regeneron (REGN) Exelixis (EXEL) Elan (ELN) Zerenex Alder Biopharmaceuticals (ALDR) Anacor (ANAC) Vertex (VRTX) Anadys (ANDS) Biocryst (BCRX) SUNESIS PHARMACEUTICALS (SNSS) NEKTAR (NKTR)) Ziofpharm (ZIOP) Sequenom (SQNM) KERYX (KERX) Telaprevir Aimmune Therapeutics (AIMT) JUNO (JUNO) ImmunoGen (IMGN) ACADIA (ACAD) ISIS (ISIS) BIOMARIN (BMRN) Tysabri NOVOCURE (NVCR) Biogen Idec (BIIB) Ridaforolimus TOKAI (TKAOI) OSI (OSIP)